MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 55 filers reported holding MAGENTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,733,000 | -34.4% | 597,607 | +0.2% | 0.00% | -50.0% |
Q4 2021 | $2,643,000 | -24.7% | 596,678 | +23.7% | 0.00% | 0.0% |
Q3 2021 | $3,512,000 | -24.4% | 482,401 | +1.6% | 0.00% | -33.3% |
Q2 2021 | $4,645,000 | +34.7% | 474,900 | +63.1% | 0.00% | +50.0% |
Q1 2021 | $3,448,000 | +73.3% | 291,200 | +14.7% | 0.00% | +100.0% |
Q4 2020 | $1,990,000 | +22.3% | 253,800 | +6.1% | 0.00% | 0.0% |
Q3 2020 | $1,627,000 | -6.4% | 239,200 | +3.3% | 0.00% | -50.0% |
Q2 2020 | $1,739,000 | +19.8% | 231,600 | +0.3% | 0.00% | 0.0% |
Q1 2020 | $1,451,000 | -58.6% | 231,000 | 0.0% | 0.00% | -33.3% |
Q4 2019 | $3,502,000 | +47.6% | 231,000 | -0.1% | 0.00% | +50.0% |
Q3 2019 | $2,373,000 | -31.1% | 231,256 | -0.9% | 0.00% | -33.3% |
Q2 2019 | $3,443,000 | -11.3% | 233,400 | -1.0% | 0.00% | -25.0% |
Q1 2019 | $3,882,000 | +152.2% | 235,700 | -12.7% | 0.00% | +100.0% |
Q4 2018 | $1,539,000 | -68.8% | 270,000 | -34.3% | 0.00% | -50.0% |
Q3 2018 | $4,937,000 | -10.8% | 411,055 | +0.3% | 0.00% | -20.0% |
Q2 2018 | $5,533,000 | – | 409,844 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 6,758,204 | $49,200,000 | 11.16% |
Aquilo Capital Management, LLC | 3,155,082 | $22,969,000 | 4.17% |
GREAT POINT PARTNERS LLC | 1,170,000 | $8,518,000 | 1.98% |
Casdin Capital, LLC | 3,901,589 | $28,404,000 | 0.71% |
Alphabet Inc. | 3,339,138 | $24,309,000 | 0.58% |
Bleichroeder LP | 434,400 | $3,162,000 | 0.51% |
Palo Alto Investors LP | 432,300 | $3,147,000 | 0.19% |
Integral Health Asset Management, LLC | 90,000 | $655,000 | 0.19% |
Orbimed Advisors | 1,892,953 | $13,781,000 | 0.15% |
HARVARD MANAGEMENT CO INC | 332,610 | $2,421,000 | 0.14% |